Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study

Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-020-00179-7
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients With Hepatocellular Carcinoma Treated With Sorafenib: A Multicenter Retrospective Study

Internal Medicine
Internal MedicineMedicine
2019English

Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Gastroenterology
Gastroenterology
2016English

The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib

Hepatology Research
HepatologyInfectious Diseases
2019English

MA10.06 Impact of Immune-Related Adverse Events on Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib

Oncology
MedicineCancer ResearchOncology
2015English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Long Duration of Stable Disease May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Acta Hepatologica Japonica
Hepatology
2012English

A Case of Advanced Hepatocellular Carcinoma Treated Successfully With Juzentaihoto

Acta Hepatologica Japonica
Hepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy